GlassScriptPhysician profile
James M Weiss
NPI 1891759874
$1,058.26
in general payments reported to CMS, 2019-2025
24 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $345 · 2021: $252 · 2024: $104 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $123.81 | 2019-2024 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $103.78 | 2019-2021 | |
| Astellas Pharma US INC | $93.86 | 2019-2020 | |
| Eisai INC. | $80.28 | 2021 | |
| Pfizer INC. | $61.79 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.52 | 2020 | |
| Exact Sciences Corporation | $58.54 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $55.76 | 2019-2020 | |
| Lilly USA, LLC | $44.38 | 2019-2025 | Kisunla, Amyvid |
| Abbvie INC. | $37.21 | 2020-2024 | |
| Sanofi Pasteur INC. | $35.62 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $34.92 | 2020-2021 | |
| Medicomp INC | $33.62 | 2025 | Telepatch Cardiac Monitor |
| Regeneron Healthcare Solutions, INC. | $27.61 | 2019 | |
| Supreme Orthopedic Systems, LLC | $26.98 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $25.37 | 2020 | |
| La Jolla Pharmaceutical Company | $24.91 | 2020 | |
| Promius Pharma LLC | $23.26 | 2019 | |
| Upsher-Smith Laboratories LLC | $21.90 | 2021 | |
| Inspire Medical Systems, INC. | $20.53 | 2024 | Inspire |
| Arbor Pharmaceuticals, INC. | $19.36 | 2020 | |
| Fortovia Therapeutics, INC. | $15.96 | 2020 | |
| Tactile Systems Technology INC | $13.95 | 2021 | |
| Seqirus USA INC | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.